Solingen
Germany
129
2022-12-29
The entities that hold a legal rights for patent applications filed by inventor Stasch Johannes-Peter:
Johannes-Peter Stasch from Solingen, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
Substituted 5-fluoro-1H-pyrazolopyridines and their use
#2 | 2020-12-24Substituted 5-fluoro-1H-pyrazolopyridines and their use
#3 | 2020-12-10Branched 3-phenylpropionic acid derivatives and their use
#4 | 2019-08-15AMINO-SUBSTITUTED IMIDAZO[1,2-A] PYRIDINECARBOXAMIDES AND THEIR USE
#5 | 2019-06-20BRANCHED 3-PHENYLPROPIONIC ACID DERIVATIVES AND THEIR USE
#6 | 2018-11-08Amino-substituted imidazo[1,2-A] pyridinecarboxamides and their use
#7 | 2018-10-04Branched 3-phenylpropionic acid derivatives and their use
#8 | 2018-09-20Substituted 5-fluoro-1H-pyrazolopyridines and their use
#9 | 2017-09-28Substituted 5-flouro-1H-pyrazolopyridines and their use
#10 | 2017-09-145-aminotetrahydroquinoline-2-carboxylic acids and their use
#11 | 2017-06-29Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
#12 | 2016-09-15Branched 3-phenylpropionic acid derivatives and their use
#13 | 2016-06-09SGC stimulators in combination with additional treatment for the therapy of cystic fibrosis
#14 | 2016-05-12SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES AND THEIR USE
#15 | 2016-05-053-aryl-substituted imidazo[1,2-A]pyridines and their use
#16 | 2015-10-01Substituted annulated triazines and use thereof
#17 | 2015-10-01AMINO-SUBSTITUTED IMIDAZO[1,2-A]PYRIDINECARBOXAMIDES AND THEIR USE
#18 | 2015-06-25Substituted aminoindane- and aminotetralinecarboxylic acids and the use thereof
#19 | 2015-06-04N-[3-(2-carboxyethyl)phenyl]piperidin-1-ylacetamide derivatives and use thereof as activators of soluble guanylate cyclase
#20 | 2015-05-285-aminotetrahydroquinoline-2-carboxylic acids and their use
#21 | 2015-04-16Substituted annellated pyrimidines and use thereof
#22 | 2015-04-02Substituted triazine derivatives and use thereof as stimulators of soluble guanylate cyclase
#23 | 2015-03-19Substituted 5-fluoro-1H-pyrazolopyridines and their use
#24 | 2015-03-05Benzyl-substituted carbamates and use thereof
#25 | 2015-01-22Substituted azabicycles and use thereof
#26 | 2014-12-04SUBSTITUTED ANNULATED PYRIMIDINES AND TRIAZINES, AND USE THEREOF
#27 | 2014-11-27Ring-fused pyrimidines and triazines and use thereof for the treatment and/or prophylaxis of cardiovascular diseases
#28 | 2014-10-16Branched 3-phenylpropionic acid derivatives and their use
#29 | 2014-09-25SGC STIMULATORS OF SGC ACTIVATORS IN COMBINATION WITH PDE5 INHBITORS FOR THE TREATMENT OF ERECTILE DYSFUNCTION
#30 | 2014-09-04Trifluoromethyl-substituted fused pyrimidines and their use
#31 | 2014-08-14HETEROARYL-SUBSTITUTED PYRAZOLOPYRIDINES AND USE THEREOF AS SOLUBLE GUANYLATE CYCLASE STIMULATORS
#32 | 2014-06-26Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
#33 | 2014-06-19SUBSTITUTED IMIDAZOPYRIDINES AND IMIDAZOPYRIDAZINES AND THE USE THEREOF
#34 | 2014-05-29Bicyclic aza heterocycles, and use thereof
#35 | 2014-05-22Substituted 3-phenylpropionic acids and the use thereof
#36 | 2014-05-08Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use
#37 | 2014-05-08Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their use
#38 | 2014-05-08Hydroxy-substituted imidazo[1,2-a]pyridinecarboxamides and their use
#39 | 2014-05-08Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
#40 | 2014-04-24Substituted imidazopyridines and the use thereof
#41 | 2014-04-10Fluoroalkyl-substituted pyrazolopyridines and use thereof
#42 | 2014-02-06Use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc)
#43 | 2014-01-305-aminotetrahydroquinoline-2-carboxylic acids and their use
#44 | 2013-12-19Substituted annellated pyrimidines and use thereof
#45 | 2013-11-14BENZIMIDAZOLE AND PYRAZOLOPYRIDINE DERIVATIVES FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASES
#46 | 2013-10-10Substituted 6-fluoro-1H-pyrazolo[4,3-b]pyridines and use thereof
#47 | 2013-09-12Substituted 5-fluoro-1H-pyrazolopyridines and their use
#48 | 2013-08-15Substituted fused imidazoles and pyrazoles and use thereof
#49 | 2013-08-08Substituted 8-alkoxy-2-aminotetralin derivatives, and use thereof
#50 | 2013-07-04Ring-fused 4-aminopyrimidines and use thereof as stimulators of soluable guanylate cyclases
#51 | 2013-06-20USE OF STIMULATORS AND ACTIVATORS OF SOLUBLE GUANYLATE CYCLASE FOR TREATING SICKLE-CELL ANEMIA AND CONSERVING BLOOD SUBSTITUTES
#52 | 2013-03-28Branched 3-phenylpropionic acid derivatives and their use
#53 | 2013-02-14Substituted 2, 6-Diamino-3, 5-Dicyano-4-Aryl-Pyridines And Their Use As Adenosine-Receptor-Selective Ligands
#54 | 2013-02-07sGC STIMULATORS OR sGC ACTIVATORS ALONE AND IN COMBINATION WITH PDE5 INHBITORS FOR THE TREATMENT OF CYSTIC FIBROSIS
#55 | 2012-07-05Substituted 1-benzylcycloalkylcarboxylic acids and the use thereof
#56 | 2012-02-09PREDICTION OF NON-FATAL AND FATAL ATHEROTHROMBOTIC EVENTS
#57 | 2012-02-02BENZIMIDAZOLE AND PYRAZOLOPYRIDINE DERIVATIVES FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASES
#58 | 2012-02-02Oxo-heterocyclically substituted alkyl carboxylic acids and use thereof
#59 | 2012-01-26Substituted 5-fluoro-1H-pyrazolopyridines and their use
#60 | 2012-01-26SGC STIMULATORS OR SGC ACTIVATORS IN COMBINATION WITH PDE5 INHIBITORS FOR THE TREATMENT OF ERECTILE DYSFUNCTION
#61 | 2011-10-06Aliphatically substituted pyrazolopyridines, and the use thereof
#62 | 2011-06-30SOLUTIONS FOR PERFUSING AND PRESERVING ORGANS AND TISSUES
#63 | 2011-06-02SUBSTITUTED 3-PHENYLPROPIONIC ACIDS AND THE USE THEREOF
#64 | 2011-05-26Cyclically substituted furopyrimidine derivatives and use thereof
#65 | 2011-04-21SGC STIMULATORS, SGC ACTIVATORS AND COMBINATIONS THEREOF FOR THE TREATMENT OF HEARING IMPAIRMENT
#66 | 2011-02-17Aza-bicyclic compounds and their use as stimulators of soluble guanylate cyclase
#67 | 2011-02-10Oxo-heterocyclic substituted carboxylic acid derivatives and the use thereof
#68 | 2010-12-16NOVEL AMINODICARBOXYLIC ACID DERIVATIVES HAVING PHARMACEUTICAL PROPERTIES
#69 | 2010-08-19sGC STIMULATORS, sGC ACTIVATORS AND COMBINATIONS FOR THE TREATMENT OF UROLOGICAL DISORDERS
#70 | 2010-08-05Lactam-substituted dicarboxylic acids and use thereof
#71 | 2010-07-01Substituted dibenzoic acid derivatives and use thereof
#72 | 2010-05-063-Tetrazolyl Indazoles, 3-Tetrazolyl Pyrazolopyridines, and use Thereof
#73 | 2010-04-22SUBSTITUTED 5-AMINOPYRAZOLES AND USE THEREOF
#74 | 2010-02-04Dicarboxylic acid derivatives and their use
#75 | 2010-02-04Pyrazolopyridine, indazole, imidazopyridine, imidazopyrimidine, pyrazolopyrazine and pyrazolopyridine derivatives as stimulators of guanylate cyclase for cardiovascular disorders
#76 | 2010-01-21novel use of activators and stimulators of soluble guanylate cyclase for the prevention or treatment of renal disorders
#77 | 2010-01-07Heterocyclic Substituted, Anellated Pyrazole Derivative and its uses
#78 | 2009-12-24Acyclically substituted furopyrimidine derivatives and use thereof
#79 | 2009-12-03Use of Activators of Soluble Guanylate Cyclase for Treating Reperfusion Damage
#80 | 2009-11-26Difluorophenol derivatives and their use
#81 | 2009-11-19Cyclopropylacetic acid derivatives and use thereof
#82 | 2009-11-19Use of Suluble Guanylate Cyclase Acitvators for Treating Acute and Chronic Lung Diseases
#83 | 2009-09-10Biphenyl compounds useful in the treatment or prevention of cardiovascular disorders
#84 | 2009-09-03Use of Activators of Soluble Guanylate Cyclase for Promoting Wound Healing
#85 | 2009-08-27Tetrazole derivatives and their use for the treatment of cardiovascular diseases
#86 | 2009-08-27Use of soluble guanylate cyclase activators for the treatment of Raynaud's Phenomenon
#87 | 2009-08-13Aminodicarboxylic acid derivatives having pharmaceutical properties
#88 | 2009-01-22MORPHINE-BRIDGED INDAZOLE DERIVATIVES
#89 | 2008-10-30Substituted phenylamino-pyrimidines
#90 | 2008-10-09Pyrrolopyridine-Substituted Benzol Derivatives for Treating Cardiovascular Diseases
#91 | 2008-06-12Hetaryloxy-substituted phenylamino pyrimidines as Rho kinase inhibitors
#92 | 2008-06-12Method For Treating Bronchoconstriction and Pulmonary Vaso-Constriction
#93 | 2008-03-06Dicarboxylic acid derivatives with pharmaceutical properties
#94 | 2007-09-27Novel Combination Containing a Stimulator of Soluble Guanylate Cyclase and a Lipid-Lowering Substance
#95 | 2007-09-13Substituted 2, 6-diamino-3, 5-dicyano-4-arylpyridines and their use as adenosine-receptor-selective ligands
#96 | 2007-08-02Substituted aminodicarboxylic acid derivatives having pharmaceutical properties
#97 | 2007-07-19Relaxin as an independent risk factor predicting mortality
#98 | 2006-11-23Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use
#99 | 2006-11-14Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof
#100 | 2006-11-02Quinoxalinones and their use especially in the treatment of cardiovascular diseases
80003 ⎘